📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RARß Agonist Drug (C286) Demonstrates Efficacy in a Pre-clinical Neuropathic Pain Model Restoring Multiple Pathways via DNA Repair Mechanisms. (2019)

First Author: Goncalves MB

Attributed to: A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.isci.2019.09.020

PubMed Identifier: 31655065

Publication URI: http://europepmc.org/abstract/MED/31655065

Type: Journal Article/Review

Volume: 20

Parent Publication: iScience

ISSN: 2589-0042